Lixte Biotechnology Holdings, Inc (LIXT) insider trading

Every open-market stock purchase and sale by Lixte Biotechnology Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Bastiaan Jeroen van der Baan (CEO), $28K, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent LIXT insider trades

DateInsiderTradeValue
May 29, 2026Stuart D Porter (Director)Bought (not open market)—
Apr 15, 2026Geordan Garrett Pursglove (CEO)Sold (not open market)$991K
Apr 15, 2026Peter Stazzone (CFO)Sold (not open market)$223K
Apr 15, 2026Lourdes Felix (Director)Sold (not open market)$101K
Apr 15, 2026Guy Warren Primus (Director)Sold (not open market)$101K
Apr 15, 2026Jason David Sawyer (Director)Sold (not open market)$89.8K
Apr 15, 2026Michael Andrew Holloway (Director)Sold (not open market)$89.8K
Apr 15, 2026Geordan Garrett Pursglove (CEO)Bought (not open market)—
Apr 15, 2026Guy Warren Primus (Director)Bought (not open market)—
Apr 15, 2026Michael Andrew Holloway (Director)Bought (not open market)—
Apr 15, 2026Peter Stazzone (CFO)Bought (not open market)—
Apr 15, 2026Lourdes Felix (Director)Bought (not open market)—
Apr 15, 2026Jason David Sawyer (Director)Bought (not open market)—
Dec 24, 2025Lourdes Felix (Director)Bought (not open market)—
Dec 24, 2025Guy Warren Primus (Director)Bought (not open market)—

Who's trading LIXT

Get free alerts when an insider at Lixte Biotechnology Holdings, Inc files a new trade →